Grace Aldrovandi, MD
Dr. Aldrovandi is the Chief of the Division of Infectious Diseases at the Children’s Hospital Los Angeles. She has over 20 years of experience caring for children with infectious diseases. Dr. Aldrovandi has been an investigator at The Saban Research Institute of Children’s Hospital Los Angeles since 2003 and leads an internationally recognized research program studying transmission of HIV in breast milk. She is also a professor of Pediatrics, Pathology, and Molecular Microbiology and Immunology at the Keck School of Medicine of the University of Southern California.
Patricia Pavlinac, PhD, MS
Dr. Pavlinac is an epidemiologist and Assistant Professor in the Department of Global Health. She co-directs the CFAR Enterics Scientific Working Group, nested within the CFAR International Core and co-directs the Gut Health and Child Survival Scientific Priority area of the Global Center for Integrated Health of Women, Adolescents, & Children (Global WACh). Dr. Pavlinac’s research aims to identify interventions to halt morbidity and mortality attributed to enteric and diarrheal diseases.
Will DePaolo, PhD
Dr. William DePaolo has recently been appointed an Associate Professor of Medicine at the University of Washington Medical Center and is the recipient of the Lynn M. and Michael D. Garvey endowed chair in Gastroenterology. Dr. DePaolo was also named Director of the Center for Microbiome Sciences & Therapeutics (CMiST) at the University of Washington, which serves as an intellectual hub for investigators, clinicians and the community interested in the human microbiome.
Hillary Hayden, PhD, MS
Dr. Hayden is a Principal Research Scientist in the Miller Lab in the Department of Microbiology at the UW where she manages the Cystic Fibrosis Research Translation Center and Research Development Program Genomics Core. She has more than 15 years of experience in bacterial genomics with expertise in bridging the biological research and informatics communities. Her research interests include bacterial genome biology and phylogenetics and the role of the microbiome in human disease. She has contributed to published microbiome research in ulcerative colitis, Crohn's Disease, juvenile idiopathic arthritis and cystic fibrosis.
Donald Nyangahu, PhD
Dr. Nyangahu graduated with PhD from the University of Cape Town under the supervision of Dr. Heather Japan. He recently relocated to Jaspan's lab at the Seattle Children's Research Institute to begin his postdoctoral research. He uses mouse models to study the role of maternal microbiome during pregnancy or lactation on offspring immunity and response to pathogens (RSV and helminths).
James Kublin, MD MPH
Dr. James Kublin is the Executive Director of the HIV Vaccine Trials Network based at Fred Hutchinson Cancer Research Center. He is also the Medical Director of the Malaria Clinical Trials Center at Seattle BioMed, and a faculty member in the Department of Global Health at the University of Washington.He has conducted extensive research on HIV and malaria in South America, SE Asia, and Africa, including clinical trials of novel therapies and vaccines.
Julia / Yue Cui, PhD MS
Dr. Cui is trained as a toxicologist, specializing in using toxicogenomic and toxicoepigenomic approaches to determine the effects of environmental chemical exposure and reprogramming the gut microbiome on the transcriptional and epigenetic regulation of genes involved in drug metabolism and obesity during development.
Sujatha Srinivasan, PhD
Dr. Srinivasan has a background in environmental and human microbiology with a keen interest in understanding how bacterial interactions in human microbial communities impact human health and disease. She has developed molecular, omics and in vitro cultivation tools to study the human microbiome. She is a Senior Staff Scientist in the Vaccine and Infectious Disease Division at Fred Hutch, and the Associate Director of the Microbiome Core of the NIH-funded UW/Fred Hutch Sexually Transmitted Infections Cooperative Research Center that is investigating the interactions between the human genital microbiome and syndromes and pathogens that contribute to STI-related morbidity.
Judd Walson, MD
Dr. Walson is an Associate Professor at the University of Washington. Dr. Walson has extensive experience in the design and implementation of large clinical trials in resource-limited settings. He has worked extensively in Kenya, Ethiopia, Bangladesh, Thailand and Nepal. Dr. Walson is particularly interested in the effect of enteric infection and composition on immunologic function and growth. Dr. Walson is the Principal Investigator for DeWorm3, which aims to demonstrate the feasibility of interrupting the transmission of soil transmitted helminths. Dr. Walson is also the Co-Director of CHAIN, a large clinical platform in five countries in Africa and Asia designed to evaluate mortality and morbidity among acutely ill children with varying degrees of malnutrition and to develop and test interventions for this high risk population.
Jennifer Balkus, PhD, MPH
Dr. Balkus is an infectious disease epidemiologist and whose research focuses on questions that interface between the vaginal microbiome and HIV/STI prevention. She is an Assistant Professor in the Department of Epidemiology and the Associate Director of the Microbicide Trials Network Statistical and Data Management Center, an NIH-supported research network that focuses on reducing sexual transmission of HIV through the development and evaluation antiretroviral-based microbicides.
Amy Willis, PhD MS
Dr. Willis is an Assistant Professor in the Department of Biostatistics at the University of Washington. Her research group develops statistical methodology to analyze ecological community data, with an emphasis on the microbiome. She is especially interested in adjusting for uncertainties in sequencing and clustering in downstream statistical analyses. Her expertise includes statistical analysis of alpha diversity, high dimensional compositional data analysis, and phylogenetic uncertainty.
Elhanan Borenstein, PhD
Dr. Borenstein is an Associate Professor of Genome Sciences and an adjunct Associate Professor of Computer Science and engineering at the University of Washington. He is also an external professor at the Santa Fe Institute for complexity science. The Borenstein lab focuses on computational study of the human microbiome, aiming to provide a predictive, mechanistic, and systems-level understanding of the microbiome in health and disease. The lab develops a variety of novel computational frameworks, integrating multi-omic microbiome data with methods inspired by systems biology, metabolic modeling, network theory, machine-learning, and statistical inference, and harnesses such frameworks for informing microbiome-based therapy and design. Dr. Borenstein is the recipient of various awards including the Alfred P. Sloan Fellowship and the NIH New Innovator Award.